Series A funding round for CANbridge Pharmaceuticals raising $10M in December 2014
Series A funding round for CANbridge Pharmaceuticals raising $10M in December 2014
| Investor | Firm Type |
|---|
| Partner |
|---|
| Venture Capital | — | |
TF CapitalLEAD | Venture Capital | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$214M
Top Valuation
-
CANbridge Pharmaceuticals raised $10M in a Series A round.
The round was announced on 12/01/14.
The round was led by Qiming Venture Partners, TF Capital.